Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Deferasirox (250mg) Tablet
Therapeutic Category
Nephrology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Deferise 250 Tablet containing Deferasirox 250 mg is a specialized iron chelation medicine formulated for patients with chronic transfusion requirements. It helps in reducing excess iron in the body, preventing organ damage, and maintaining overall health in hematological conditions.
Deferasirox works by binding to free iron in the bloodstream and promoting its elimination via urine and feces. This process ensures safe iron levels and helps prevent complications such as liver and cardiac damage.
The tablet offers a convenient oral therapy option for iron chelation, improving patient compliance and providing consistent management of iron overload. Its targeted action ensures effective control and protection against iron-related complications.
With rising awareness of iron overload and demand for safe chronic care therapies, this formulation offers strong market potential. Its clinical reliability, consistent prescriptions, and growing acceptance make it an ideal choice for expanding reach and driving sustained growth in the hematology segment.
Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, or mild skin rash. Rarely, serious side effects such as liver or kidney dysfunction, hearing or vision changes, or severe allergic reactions may occur and require immediate medical attention.
Deferise 250 Tablet is indicated for the treatment of chronic iron overload in patients with transfusion-dependent anemias such as thalassemia, sickle cell disease, or other conditions requiring repeated blood transfusions. It helps reduce elevated iron levels, prevent complications associated with iron toxicity, and maintain proper organ function.
This medicine should be used under strict medical supervision. Patients with pre-existing liver or kidney conditions should consult their healthcare provider before use. Regular monitoring of iron levels, liver, and kidney function is recommended during treatment to ensure safety and effectiveness.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Atracurium (10mg) Injection
Composition : Thiocolchicoside (4mg) Capsule
Composition : Thiocolchicoside (4mg) Injection
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Chlorzoxazone (250mg) Tablet
Composition : Drotaverine (80mg) + Aceclofenac (100mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (4mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Baclofen (10mg) Tablet
Composition : Baclofen (20mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Deferasirox 250mg Tablet has strong demand in the hematology and chronic care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in iron overload management, especially in patients requiring repeated blood transfusions such as thalassemia and chronic anemia cases. It strengthens their hematology and specialty care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Deferasirox 250mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic therapy demand, repeat prescriptions, and strong specialty-care market opportunities when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hematology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.